台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    150.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    7
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-統一-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/3000.000.1156.98150.00-0.110-0.60%
2024/04/2600.000154.00154.50010-0.28%
2024/02/190151.0000.00152.50080.47%
2023/09/121165.0000.00166.001146.80%
2023/06/1200.002178.00171.50-253-3.73%
2023/05/2900.001184.00186.00-161-1.62%
2023/05/261185.0000.00185.001611.62%
2023/05/1100.002175.00178.50-260-3.31%
2023/05/0800.001185.00185.00-158-1.71%
2023/05/051181.5000.00182.001581.71%
2023/04/1700.001182.50181.00-147-2.12%
2023/02/0700.001161.00162.00-166-1.51%
2023/01/311156.0000.00156.001661.50%
2022/12/161150.5000.00151.501611.63%
2022/11/233140.0000.00140.003714.20%
2022/11/1500.000140.00138.50077-0.02%
2022/11/100138.0000.00136.000810.01%
2022/11/090138.0000.00139.000840.01%
2022/11/011136.5000.00138.5011001.00%
2022/10/0600.001159.00159.50-1101-0.99%
2022/09/291143.5000.00143.5011030.97%
2022/08/3000.001176.50175.50-191-1.09%
2022/08/1900.001169.00169.00-177-1.28%
2022/06/131135.501132.00133.500430.00%
2022/06/101133.5000.00133.001412.42%
2022/01/2600.002128.50128.00-258-3.40%
2021/04/0900.001118.00117.50-153-1.87%
2020/12/1800.000.3109.00109.00-0.331-0.88%
2020/11/1200.000.1110.50111.00-0.159-0.17%
2020/10/080.1114.5000.00115.000.11140.09%
2020/09/101115.5000.00113.5011300.76%
2020/09/021121.0000.00121.0011270.78%
2020/08/121124.5000.00123.501991.01%
2020/04/20197.2000.0097.201921.08%
2019/11/181115.0000.00115.001601.64%
2019/09/2600.002134.50133.50-2107-1.86%
2019/09/111141.5000.00141.5011140.88%
2019/09/101141.0000.00142.0011130.88%
2019/06/2700.003127.00126.00-347-6.30%
2019/06/2400.001126.00126.00-146-2.14%
2019/05/091123.5000.00125.001651.52%
2019/04/241119.0000.00119.001591.69%
2019/03/281114.0000.00114.001502.00%
2019/03/262117.0000.00116.502494.06%
2019/03/1200.001124.50124.00-140-2.47%
2019/03/1100.002125.00123.50-239-5.11%
2019/03/061113.0000.00113.501323.06%
2019/02/201103.5000.00103.001253.89%
2019/02/111105.0000.00104.001253.90%
2019/01/18196.1000.0096.101204.79%
2018/11/1300.00293.1093.30-244-4.52%
2018/10/032100.5000.00100.502494.03%
2018/08/141105.5000.00105.501811.23%
2018/05/031166.001167.50163.0003670.00%
2018/04/2400.001165.00161.50-1374-0.27%
2018/04/231180.002181.00172.00-1364-0.27%
2018/04/201172.5000.00173.0013420.29%
2018/04/0900.002168.00168.00-2322-0.62%
2018/03/311152.501153.50153.5002880.00%
2018/03/2900.001146.50147.50-1270-0.37%
2018/03/221144.0000.00139.0012670.37%
2018/03/091134.501136.00136.5002920.00%
2018/03/0500.001142.50140.50-1306-0.33%
2018/02/2700.001137.00136.00-1313-0.32%
2018/02/2200.001135.00133.00-1314-0.32%
2018/02/211134.0000.00130.5013110.32%
2018/02/121142.5000.00136.0013010.33%
2018/02/012186.5000.00182.5023230.62%
2018/01/251177.5000.00175.5013170.32%
2018/01/1800.001175.50171.50-1300-0.33%
2018/01/101165.001170.00166.5002850.00%
2018/01/0300.001154.00153.00-1269-0.37%
2018/01/0200.001153.50152.00-1270-0.37%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章